Immortalization of human melanocytes does not alter the de novo properties of nitric oxide to induce cell detachment from extracellular matrix components via cGMP

In Vitro Cellular and Developmental Biology - Animal

Volumn 44, Issue 8-9, 2008, Pages 385-395

  Ivanova, Krassimira ^a   Lambers, Britta ^a   Van Den Wijngaard, Rene ^b   Le Poole, I Caroline ^c   Grigorieva, Olga ^d   Gerzer, Rupert ^a   Das, Pranab K ^b  

^a GERMAN AEROSPACE CENTER DLR   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d INSTITUTE OF BIOMEDICAL PROBLEMS   (Russian Federation)

Author keywords

cGMP; Detachment; Immortalized melanocytes; Nitric oxide; Soluble guanylyl cyclase

Indexed keywords

1 [N (3 AMMONIOPROPYL) N (PROPYL)AMINO]DIAZEN 1 IUM 1,2 DIOLATE; 1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; CYCLIC GMP; GUANYLATE CYCLASE; LINSIDOMINE; MELANIN; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; PROTEIN E6; PROTEIN E7; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVITY; CELL IMMORTALIZATION; CHEMICAL COMPOSITION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MELANOCYTE; MELANOMA CELL; METASTASIS POTENTIAL; OUTCOME ASSESSMENT; PROTEIN EXPRESSION;

CELL ADHESION; CYCLIC GMP; EXTRACELLULAR MATRIX; GUANYLATE CYCLASE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MELANOCYTES; NITRIC OXIDE; ONCOGENE PROTEINS, VIRAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANSFECTION;

HUMAN PAPILLOMAVIRUS;

EID: 58049211401     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-008-9113-1     Document Type: Article

References (53)

1. D. Bandyopadhyay N. Timchenko T. Suwa P. J. Hornsby J. Campisi E. E. Medrano 2001 The human melanocyte: a model system to study the complexity of cellular aging and transformation in non-fibroblastic cells Exp. Gerontol. 36 1265 1275
2. F. Bittinger J. L. González-García C. L. Klein C. Brochhausen F. Offner C. J. Kirkpatrick 1998 Production of superoxide by human malignant melanoma cells Melanoma. Res. 8 381 387
3. P. Borst C. de Wolf K. van de Wetering 2007 Multidrug resistance-associated proteins 2, 4, and 5. Pflugers Arch. Eur. J. Physiol. 453 661 673
4. M. M. Cals-Grierson A. D. Ormerod 2004 Nitric oxide function in the skin Nitric Oxide 10 179 193
5. Z. S. Chen K. Lee G. D. Kruh 2001 Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine J. Biol. Chem. 276 33746 33754
6. E. H. Danen S. Aota A. A. van Kraats K. M. Yamada D. J. Ruiter G. N. van Muijen 1995 Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of integrin alpha 5 beta 1 J. Biol. Chem. 270 21612 21618
7. E. H. Danen G. N. van Muijen E. van de Wiel-van Kemenade K. F. Jansen D. J. Ruiter 1993 Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and in nonmetastatic and highly metastatic human melanoma cells Int. J. Cancer. 54 315 321
8. R. G. Deeley C. Westlake S. P. Cole 2006 Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins Physiol. Rev. 86 849 899
9. M. L. Dell'Anna M. Picardo 2006 A review and a new hypothesis for non-immunological pathogenic mechanisms in vitiligo Pigment. Cell Res. 19 406 411
10. S. A. Doggrell 2005 Clinical potential of nitric oxide-independent soluble guanylyl cyclase activators Curr. Opin. Investig. Drugs. 6 874 878
11. S. Ekmekcioglu J. Ellerhorst V. G. Prieto M. M. Johnson L. D. Broemeling E. A. Grimm 2006 Tumor iNOS predicts poor survival for stage III melanoma patients Int. J. Cancer. 119 861 866
12. S. Ekmekcioglu C. H. Tang E. A. Grimm 2005 NO news is not necessarily good news in cancer Curr. Cancer. Drug. Targets. 5 103 115
13. O. V. Evgenov P. Pacher P. M. Schmidt G. Haskó H. H. H. Schmidt J. P. Stasch 2006 NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential Nat. Rev. Drug. Discov. 5 755 768
14. M. Feelisch J. Ostrowski E. Noak 1989 On the mechanism of NO release from sydnonimines J. Cardiovasc. Pharmacol. 14 S13 S22
15. M. Gilchrist S. D. McCauley A. D. Befus 2004 Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production Blood 104 462 469
16. S. Heimerl A. K. Bosserhoff T. Langmann J. Ecker G. Schmitz 2007 Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells Melanoma Res. 17 265 273
17. M. Ikeguchi T. Ueta Y. Yamane Y. Hirooka N. Kaibara 2002 Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma Clin. Cancer Res. 8 3131 3136
18. A. O. Iuga A. A. Qureshi E. A. Lerner 2004 Nitric oxide is toxic to melanocytes in vitro Pigment. Cell Res. 17 302 306
19. K. Ivanova I. Block P. K. Das R. Gerzer 2006 Role of cyclic GMP signaling in the melanocyte response to hypergravity Signal Transduction. 6 406 413
20. K. Ivanova P. K. Das R. van den Wijngaard T. Klockenbring V. Malcharzyk C. Drummer 2001 Differential expression of functional guanylyl cyclases in melanocytes: Absence of nitric oxide-sensitive isoform in metastatic cells J. Invest. Dermatol. 116 409 416
21. K. Ivanova I. C. Le Poole R. Gerzer W. Westerhof P. K. Das 1997 Effects of nitric oxide on the adhesion of melanocytes to extracellular matrix components J. Pathol. 183 469 476
22. 2+ and on aggregation of human platelets Eur. J. Pharmacol. Mol. Pharmacol. Sect. 244 37 47
23. K. Ivanova R. van den Wijngaard R. Gerzer W. H. Lamers P. K. Das 2005 Non-lesional vitiliginous melanocytes are not characterized by an increased proneness to nitric oxide-induced apoptosis Exp. Dermatol. 14 445 453
24. K. Ivanova N. H. Zadeh I. Block P. K. Das R. Gerzer 2004 Stimulation of cyclic GMP efflux in human melanocytes by hypergravity generated by centrifugal acceleration Pigment. Cell Res. 17 471 479
25. G. Jedlitschky B. Burchell D. Keppler 2000 The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides J. Biol. Chem. 275 30069 30074
26. L. K. Keefer R. W. Nims K. M. Davies D. A. Wink 1996 NONOates (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms Methods. Enzymol. 268 281 293
27. M. Kool M. de Haas G. L. Scheffer R. J. Scheper M. J. T. van Eijk J. A. Juijn 1997 Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines Cancer Res. 57 3537 3547
28. M. Kuhn 2003 Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A Circ. Res. 93 700 709
29. I. C. Le Poole R. E. Boissy R. Sarangarajan J. Chen J. J. Forristal 2000 PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum In Vitro Cell Dev. Biol. Anim. 36 309 319
30. I. C. Le Poole F. M. van den Berg R. M. van den Wijngaard D. A. Galloway P. J. van Amstel A. A. M. Buffing 1997 Generation of a human melanocyte cell line by introduction of HPV16 E6 and E7 genes In Vitro Cell Dev. Biol. Anim. 33 42 49
31. T. H. Lee M. S. Lee M. Y. Lu 1972 Effects of a-MSH on melanogenesis and tyrosinase of B-16 melanoma Endocrinology 91 1180 1188
32. O. H. Lowry N. J. Rosebrough A. L. Farr R. J. Randall 1951 Protein measurements with the Folin phenol reagent J. Biol. Chem. 193 265 275
33. P. Meredith S. Sarna 2006 The physical and chemical properties of eumelanin Pigment. Cell. Res. 19 572 594
34. F. L. Meyskens Jr H. V. Chau N. Tohidian J. Buckmeier 1997 Luminol-enhanced chemiluminescent response of human melanocytes and melanoma cells to hydrogen peroxide stress Pigment. Cell. Res. 10 184 189
35. K. N. Pandey 2005 Biology of natriuretic peptides and their receptors Peptides 26 901 932
36. C. Poulopoulou L. M. Nowak 1998 Extracellular 3′,5′ cyclic guanosine monophosphate inhibits kainite-activated responses in cultured mouse cerebellar neurons J. Pharmacol. Exp. Ther. 286 99 109
37. C. Romero-Graillet E. Aberdam N. Biagioli W. Massabni J. P. Ortonne R. Ballotti 1996 Ultraviolet B radiation acts through the nitric oxide and cGMP signal transduction pathway to stimulate melanogenesis in human melanocytes J. Biol. Chem. 271 28052 28056
38. O. Salvucci M. Carsana I. Bersani G. Tragni A. Anichini 2001 Antiapoptotic role of endogenous nitric oxide in human melanoma cells Cancer. Res. 61 318 326
39. C. S. Sander F. Hamm P. Elsner J. J. Thiele 2003 Oxidative stress in malignant melanoma and non-melanoma skin cancer Br. J. Dermatol. 148 913 922
40. M. Sasaki T. Horikoshi H. Uchiwa Y. Miyachi 2000 Up-regulation of tyrosinase gene by nitric oxide in human melanocytes Pigment. Cell. Res. 13 248 252
41. U. Schindler H. Strobel K. Schönafinger W. Linz M. Löhn P. A. Martorana 2006 Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase Mol. Pharmacol 69 1260 1268
42. A. Schrammel S. Behrends K. Schmidt D. Koesling B. Mayer 1996 Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase Mol. Pharmacol. 50 1 5
43. J. D. Schuetz M. C. Connelly D. Sun S. G. Paibir P. M. Flynn R. V. Srinivas 1999 MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs Nat. Med. 5 1048 1051
44. N. P. Smit H. van den Meulen H. K. Koerten R. M. Kolb A. M. Mommaas E. G. Lentjes 1997 Melanogenesis in cultured melanocytes can be substantially influenced by L-tyrosine and L-cysteine J. Invest. Dermatol. 109 796 800
45. J. P. Stasch P. M. Schmidt P. I. Nedvetsky T. Y. Nedvetskaya K. H. Arun S. Meurer 2006 Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels J. Clin. Invest. 116 2552 2561
46. E. V. Sviderskaya V. C. Gray-Schopfer S. P. Hill N. P. Smit T. J. Evans-Whipp J. Bond 2003 p16/Cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression J. Natl. Cancer Inst. 95 723 732
47. G. Szakács J. P. Annereau S. Lababidi U. Shankavaram A. Arciello K. J. Bussey 2004 Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells Cancer Cell 6 129 137
48. S. Takeuchi W. Zhang K. Wakamatsu S. Ito V. J. Hearing K. H. Kraemer 2004 Melanin acts as a potent UVB photosensitizer to cause atypical mode of cell deaths in murine skin Proc. Natl. Acad. Sci. U S A 101 15076 15081
49. R. M. Touyz S. Picard E. L. Schiffrin C. F. Deschepper 1997 Cyclic GMP inhibits a pharmacologically distinct Na+/H+ exchanger variant in cultured rat astrocytes via an extracellular site of action J. Neurochem. 68 1451 1461
50. G. N. van Muijen L. M. Cornelissen C. F. Jansen C. G. Figdor J. P. Johnson E. B. Bröcker 1991 Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografied into nude mice Clin. Exp. Metastasis. 9 259 272
51. R. M. van den Wijngaard J. Aten A. Scheepmaker I. C. Le Poole A. J. Tigges W. Westerhof 2000 Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo Br. J. Dermatol. 143 573 581
52. J. Wijnholds C. A. Mol L. van Deemter M. de Haas G. L. Scheffer F. Baas 2000 Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs Proc. Natl. Acad. Sci. U S A 97 7476 7481
53. K. Zepter A. C. Häffner U. Trefzer C. A. Elmets 1995 Reduced growth factor requirements and accelerated cell cycle kinetics in adult human melanocytes transformed with SV40 large T antigen J. Invest. Dermatol. 104 755 762